Literature DB >> 1707655

Degenerate binding of immunogenic peptides to HLA-DR proteins on B cell surfaces.

R Busch1, G Strang, K Howland, J B Rothbard.   

Abstract

Binding of linear fragments of protein antigens to class I or class II molecules of the MHC is necessary for the stimulation of a cellular immune response. This report describes the binding of a biotinylated T cell determinant from influenza hemagglutinin to class II proteins on the surface of Epstein-Barr virus-transformed B lymphocytes. The rapid, simple, and quantitative binding assay involves flow cytometric analysis of transformed B cells stained with fluoresceinated streptavidin following incubation with the biotinylated peptide. Binding of the biotinylated peptide required cell surface expression of human class II molecules, and was inhibited by an anti-HLA-DR monoclonal antibody as well as the unbiotinylated natural determinant. Rates of association and dissociation of the peptide were similar to those reported for purified MHC class II proteins, and the peptide bound only approximately 1% of the DR molecules expressed on the cell surface. When assayed on many different DR-homozygous B cell lines, the biotinylated hemagglutinin T cell determinant bound to HLA-DR on each cell line. The degeneracy of peptide binding to B cell lines was not unique to the hemagglutinin peptide because three other biotinylated T cell determinants failed to bind to class II deficient B-lymphoblastoid cells but bound to varying degrees to multiple DR-homozygous lines.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1707655     DOI: 10.1093/intimm/2.5.443

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  33 in total

1.  HLA-DR1001 presents "altered-self" peptides derived from joint-associated proteins by accepting citrulline in three of its binding pockets.

Authors:  Eddie A James; Antonis K Moustakas; John Bui; George K Papadopoulos; George Bondinas; Jane H Buckner; William W Kwok
Journal:  Arthritis Rheum       Date:  2010-10

2.  Constitutive endocytosis and recycling of major histocompatibility complex class II glycoproteins in human B-lymphoblastoid cells.

Authors:  P A Reid; C Watts
Journal:  Immunology       Date:  1992-12       Impact factor: 7.397

3.  The effect of a single amino acid substitution within the V3 loop of HIV-1 gp120 on HLA-DR1-restricted CD4 T-cell recognition.

Authors:  M H Fernandez; A Faith; J A Higgins; J Weber; A D Rees
Journal:  Immunology       Date:  1995-06       Impact factor: 7.397

4.  T-cell, adhesion, and B-cell epitopes of the cell surface Streptococcus mutans protein antigen I/II.

Authors:  C G Kelly; S Todryk; H L Kendal; G H Munro; T Lehner
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

5.  Mapping of specific and promiscuous HLA-DR-restricted T-cell epitopes on the Plasmodium falciparum 27-kilodalton sexual stage-specific antigen.

Authors:  C E Contreras; I N Ploton; R F Siliciano; C L Karp; R Viscidi; N Kumar
Journal:  Infect Immun       Date:  1998-08       Impact factor: 3.441

6.  Measurement of MHC/peptide interactions by gel filtration or monoclonal antibody capture.

Authors:  John Sidney; Scott Southwood; Carrie Moore; Carla Oseroff; Clemencia Pinilla; Howard M Grey; Alessandro Sette
Journal:  Curr Protoc Immunol       Date:  2013-02

Review 7.  Epitope prediction and identification- adaptive T cell responses in humans.

Authors:  John Sidney; Bjoern Peters; Alessandro Sette
Journal:  Semin Immunol       Date:  2020-10-31       Impact factor: 11.130

8.  Molecular determinants of peptide binding to two common rhesus macaque major histocompatibility complex class II molecules.

Authors:  J L Dzuris; J Sidney; H Horton; R Correa; D Carter; R W Chesnut; D I Watkins; A Sette
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

9.  Differential expansion of T-cell receptor variable beta subsets after antigenic stimulation in patients with different outcomes of hepatitis C infection.

Authors:  Rainer P Woitas; Martin Sippel; Eva-Maria Althausen; Hans H Brackmann; Bettina Kochan; Bertfried Matz; Jürgen K Rockstroh; Tilman Sauerbruch; Ulrich Spengler
Journal:  Immunology       Date:  2002-07       Impact factor: 7.397

Review 10.  The optimization of helper T lymphocyte (HTL) function in vaccine development.

Authors:  J Alexander; J Fikes; S Hoffman; E Franke; J Sacci; E Appella; F V Chisari; L G Guidotti; R W Chesnut; B Livingston; A Sette
Journal:  Immunol Res       Date:  1998       Impact factor: 2.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.